Search the Newsreel

Top Aerospace & Defense stock pick from B Riley By Investing.com

B Riley has identified leading investment opportunities in the Aerospace & Defense sector, specifically highlighting VSE Corporation (VSEC) as a top pick. VSEC reported strong second-quarter results, exceeding expectations with significant revenue and adjusted EBITDA growth driven by organic expansion and strategic acquisitions. The …

Sinotruk Hong Kong Sets Board Meeting to Review Interim Results and Dividend

B. Riley Adjusts DoubleDown Interactive PT to $24 From $22, Maintains Buy Rating

B. Riley has adjusted its price target for DoubleDown Interactive Co., Ltd. (DDI) from $22 to $24, while maintaining a Buy rating on the stock. This update comes after the company's Q2 2026 earnings call on August 11, which reported increases in both earnings …

Renaissance Technologies LLC Purchases New Holdings in B. Riley Financial, Inc. $RILY

MoonLake’s Psoriatic Arthritis Drug Shows Promise In Late-Stage Study

MoonLake Immunotherapeutics announced positive Week 16 topline results from its Phase 3 IZAR-1 trial for sonelokimab in biologic-naïve adults with active psoriatic arthritis, meeting all primary and secondary clinical endpoints. Despite the positive results, the stock fell over 6%. The company also reported strong …

Top UK Dividend Stocks to Watch: Arbuthnot Banking Group (LSE:ARBB)

Sinotrans Sets August Board Meeting to Review Interim Results and Dividend Plan

(NEWT) Movement as an Input in Quant Signal Sets

Newtekone Inc. (NASDAQ: NEWT) is showing weak near and mid-term sentiment but a strong long-term outlook, with support currently being tested. The article details three AI-generated trading strategies (Position, Momentum Breakout, Risk Hedging) and provides multi-timeframe signal analysis, highlighting a 38.5:1 risk-reward setup. Investors …

technotrans SE (WBO:TTR1) (Q2 2026) Earnings Call Highlights: Margin Resilience and Strategic ...

This article first appeared on GuruFocus. Revenue: EUR113.3 million in H1 2026, down 6% from EUR120.6 million in the prior year. EBIT: EUR8.0 million in H1 2026, compared to EUR8.4 million one year ago. EBIT Margin: Increased to 7.1% from 7.0% in the prior …

MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price Down 5.3% - Time to Sell?

Compass Diversified raised to Buy at B. Riley after Q2 results (CODI:NYSE)

B. Riley Securities upgraded Compass Diversified (CODI) to Neutral from Buy following the company's Q2 results. The upgrade is partly based on the expectation that CODI will continue to deleverage through divestitures and organic growth. The company's Q2 performance, excluding Lugano and Sterno, was …

Immunotech Biopharm Sets August Board Meeting to Approve Interim Results

B.Riley upgrades Compass Diversified stock rating on earnings beat

B.Riley has upgraded Compass Diversified (NYSE:CODI) to Buy from Neutral and raised its price target to $15.00 following the company's strong second-quarter earnings. The company reported adjusted EBITDA of $65.6 million, significantly exceeding B.Riley's estimates, and its stock has surged 131% year-to-date. Analysts anticipate …

B. Riley Adjusts Gladstone Investment Price Target to $17 From $16.50, Maintains Buy Rating

B. Riley has increased its price target for Gladstone Investment Corporation (GAIN) to $17 from $16.50, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook on the company's valuation. The news was published on August 11, 2026, at 08:00 …

Gillanders Arbu Standalone June 2026 Net Sales at Rs 81.21 crore, up 3.95% Y-o-Y

KNOT Offshore Partners Q2 Results: Earnings call set for Sept 4

KNOT Offshore Partners LP (NYSE: KNOP) is scheduled to release its Q2 2026 financial results before the market opens on Friday, September 4, 2026. A conference call will follow at 9:30 AM ET on the same day for investors and interested parties to discuss …

KNOT Offshore Partners LP Announces 2nd Quarter 2026 Earnings Results Conference Call

Keynote Financial Services Ltd is Rated Strong Sell

B. Riley Financial Has Lowered Expectations for Energy Fuels (NYSEAMERICAN:UUUU) Stock Price

B. Riley Financial has reduced its price target for Energy Fuels (NYSEAMERICAN:UUUU) from $27 to $25, while maintaining a "Buy" rating, suggesting a significant upside. Despite missing quarterly earnings estimates, analysts generally remain bullish with a consensus "Buy" rating and an average target price …

B. Riley Financial Lowers Lionsgate Studios (NYSE:LION) Price Target to $16.00

B. Riley Financial has lowered its price target for Lionsgate Studios (NYSE:LION) from $17.00 to $16.00, while maintaining a "neutral" rating. This new price target suggests a potential upside of approximately 27% from the current share price of $12.60. Despite the lowered target, analyst …

Vanda Pharmaceuticals' (VNDA) Buy Rating Reaffirmed at B. Riley Financial

B. Riley Financial has reaffirmed its "buy" rating for Vanda Pharmaceuticals (VNDA) but lowered its price target from $17 to $12, still implying a significant upside of 145%. Despite this, the company's shares dropped by 1.9% to $4.91 after reporting an EPS loss of …

TripAdvisor (NASDAQ:TRIP) Given New $12.50 Price Target at B. Riley Financial

Scinai Names Eran Kuratz to Lead CDMO Supply Chain and Business Processes

Scinai Immunotherapeutics Ltd. has appointed Eran Kuratz as the head of supply chain and business process administration for its Scinai Biopharma Services subsidiary. This strategic move aims to strengthen operational leadership and integrate the company's expanded contract development and manufacturing organization (CDMO) across its …

MoonLake Immunotherapeutics (NASDAQ:MLTX) Releases Earnings Results, Beats Estimates By $0.08 EPS

MoonLake Immunotherapeutics (MLTX) deepens loss but ends H1 2026 with $537M cash and key Phase 3 wins

Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

Scinai Immunotherapeutics has appointed Eran Kuratz as Head of Supply Chain and Business Process Administration for its CDMO subsidiary, Scinai Biopharma Services. This appointment aims to strengthen operational infrastructure and support the integration and scaling of Scinai's expanded CDMO platform, which now includes two …

B Riley Financial Inc (RILY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for B Riley Financial Inc (RILY), detailing future EPS and revenue growth estimates. It includes current stock information, market capitalization, and P/E TTM. The content also features a peer comparison of other investment banking and investment services companies …

Pollard Banknote (TSE:PBL) Stock Price Passes Below 200-Day Moving Average - Here's What Happened

KNOT Offshore Partners (NYSE:KNOP) Stock Rating Lowered by Wall Street Zen

B. Riley Financial (NASDAQ:RILY) Rating Lowered to Hold at Wall Street Zen

NewtekOne, Inc. Stock 12‑Month Price Target Raised to $17.4, Implies 16% Upside

NewtekOne, Inc. (NEWT) has seen its average 12-month price target raised from $17.2 to $17.4 by five analysts, suggesting a 16% potential upside from its August 6 closing price. The consensus rating among seven covering analysts has shifted to "Buy," with two Buys, five …

NewtekOne Inc (NEWT) Earnings Forecast: Future EPS & Revenue Growth Estimates

NewtekOne Inc (NEWT) has an earnings forecast score of 6.57, ranking 254th in the Banking Services industry, with an average price target of $14.00. Based on 7 analyst ratings, the stock currently holds a "Hold" trend. The company's expected revenue for the next quarter …

NewtekOne, Inc. - 8.00% Fixed Rate Senior Notes due 2028 Revenue Breakdown – NASDAQ:NEWTI

This article provides a revenue breakdown for NewtekOne, Inc.'s 8.625% Fixed Rate Senior Notes due 2029, traded under the symbol NEWTH on the Blue Ocean Alternative Trade System (BOATS). It highlights the availability of financial data, including statements, statistics, dividends, earnings, and segment performance, …

Scinai Immunotherapeutics Ltd (SCNI) Stock News Today

This article provides an overview of Scinai Immunotherapeutics Ltd (SCNI) stock information from TradingKey. It shows the current stock price, recent performance, market capitalization, and various financial and analytical tools available on the platform. The news section indicates that more updates are expected soon.

Scinai Immunotherapeutics Ltd (SCNI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Scinai Immunotherapeutics Ltd (SCNI), noting that no specific earnings forecast score is available for the company, contrasting with the Biotechnology & Medical Research industry average. It highlights the current stock price, market capitalization, and indicates that relevant …

B. Riley raises CleanSpark target to $26 on AI data-center portfolio

B. Riley Securities has increased its price target for CleanSpark (NASDAQ: CLSK) to $26 from $19, maintaining a Buy rating, largely due to the company's expanding AI/HPC data-center portfolio. This new target is 104% above CleanSpark's recent closing price, based on their fiscal third-quarter …